Lauge Østergaard to Toll-Like Receptor 9
This is a "connection" page, showing publications Lauge Østergaard has written about Toll-Like Receptor 9.
Connection Strength
0.285
-
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 Jun 15; 64(12):1686-1695.
Score: 0.168
-
Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice. Infect Immun. 2012 May; 80(5):1744-52.
Score: 0.117